Selected Publications

Academic Article

Year Title Altmetric
2021 New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case reportBMC Pediatrics.  21. 2021
2021 Biologic switching among nonsystemic juvenile idiopathic arthritis patients: A cohort study in the childhood arthritis and rheumatology research alliance registryJournal of Rheumatology.  48:1322-1329. 2021
2021 Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and CaregiversArthritis Care and Research.  73:374-385. 2021
2021 Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in ChildrenAmerican Journal of Epidemiology.  190:403-412. 2021
2020 Alagille Syndrome and Chronic Arthritis: An International Case SeriesJournal of Pediatrics.  218:228-230.e1. 2020
2020 Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic LymphohistiocytosisArthritis and Rheumatology.  72:326-334. 2020
2019 Characteristics of coexisting localized scleroderma and inflammatory arthritis.European Journal of Rheumatology.  1-5. 2019
2019 Establishing an updated core domain set for studies in juvenile idiopathic arthritis: A report from the OMERACT 2018 JIA workshopJournal of Rheumatology.  46:1006-1013. 2019
2018 Aortitis With an Aneurysm at Initial Presentation of Crohn Disease.Journal of Pediatric Gastroenterology and Nutrition.  67:e12-e13. 2018
2018 Aortitis with an Aneurysm at Initial Presentation of Crohn DiseaseJournal of Pediatric Gastroenterology and Nutrition.  67:e12-e13. 2018
2018 Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitorsAnnals of the Rheumatic Diseases.  77:1012-1016. 2018
2017 Evidence for updating the core domain set of outcome measures for juvenile idiopathic arthritis: Report from a special interest group at OMERACT 2016Journal of Rheumatology.  44:1884-1888. 2017
2017 Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United StatesArthritis and Rheumatology.  69:1733-1740. 2017
2016 The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis 2016
2016 Ustekinumab as a Therapeutic Option for Children with Refractory Enthesitis-Related Arthritis 2016
2014 Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitorsJournal of Rheumatology.  41:2078-2084. 2014
2014 Risk of malignancy associated with biologic agents in pediatric rheumatic diseaseCurrent Opinion in Rheumatology.  26:538-542. 2014
2013 Brief report: Incidence of selected opportunistic infections among children with juvenile idiopathic arthritisArthritis and Rheumatism.  65:1384-1389. 2013
2013 What is the background incidence of malignancy in children with rheumatic disease?Current Rheumatology Reports.  15. 2013
2011 Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter seriesArthritis and Rheumatism.  63:545-555. 2011


Year Title Altmetric
2018 Diskitis.  302-303. 2018
2018 Spondyloarthropathy.  872-873. 2018

Education And Training

  • UAB/Children's of Alabama, Residency
  • UAB/Children's of Alabama, Postdoctoral Fellowship
  • Doctor of Medicine, Eastern Virginia Medical School 2008
  • Full Name

  • Melissa Mannion